MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Modulating neuronal activity in dopaminergic neurons to promote their survival

M.A. Bernardi, N. Baffa-Trasci, O. Gershanik, M.E. Avale, J.E. Ferrario (Caba, Argentina)

Meeting: 2016 International Congress

Abstract Number: 789

Keywords: Dopaminergic neurons

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To manipulate the activity of dopaminergic (DA) neurons in culture using pharmacological and molecular tools to promote their survival.

Background: Parkinson’s disease is a neurodegenerative condition caused by progressive degeneration of DA neurons in the Substantia Nigra pars compacta. Although the causes that lead to DA neurons death remain unknown, their degeneration may involve oxidative stress, disturbed calcium homeostasis and mitochondrial dysfunction. Recent findings suggest that electrical activity could play an important role in determining their survival. Pharmacological blockade of the electrical activity in vitro can induce cell death while increasing electrical activity induces neuron survival, probably involving the increase of intracellular Ca2+ levels. However, some evidences suggest that an excessive increase in intracellular Ca2+ can generate toxic conditions for DA neurons.

Methods: Primary DA cultures were obtained from ventral mesencephalon of mouse embryos dissected at gestational day 13 (E13.5). Pharmacological treatments were carried out using Nicotine alone or combined with Tetraethylammonium (TEA), an agent that blocks voltage-dependent K+ channels, thus increasing electrical activity. These treatments were combined with transduction with either inhibitory or excitatory heterologous Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) that were delivered into postmitotic neurons by lentiviral (LV) particles. Cultures were treated with clozapine-n-oxide (CNO). After treatments neurons were fixed at days in vitro (DIV) 2, 5, 9 or 14th and then immunostained for tyrosine hydroxylase. The number of DA neurons was determined by direct quantification in an epifluorescent microscope.

Results: We reproduced the in vitro model of DA degeneration in mouse cell culture and were able to artificially modulate their electrical activity using molecular tools to control neuronal survival. Nicotine and TEA promoted DA survival at DIV 14, and enhancement of electrical activity with excitatory M3 DREADD prevented DA cell death when treated with CNO.

Conclusions: DREADDs delivered with LV vectors are efficient to transduce DA neurons in vitro and represent a good approach to manipulate their activity in order to study the mechanism of activity-mediated survival. Further work is under way to demonstrate the role of artificial electrical manipulation on the survival of DA neurons in vitro and vivo.

To cite this abstract in AMA style:

M.A. Bernardi, N. Baffa-Trasci, O. Gershanik, M.E. Avale, J.E. Ferrario. Modulating neuronal activity in dopaminergic neurons to promote their survival [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/modulating-neuronal-activity-in-dopaminergic-neurons-to-promote-their-survival/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/modulating-neuronal-activity-in-dopaminergic-neurons-to-promote-their-survival/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley